Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Sun Pharmaceuticals Industries Ltd
  Sun Pharma intimates of acceptance of regulatory filings for tildrakizumab | [24-May-2017]
  Sun Pharma slumps as Taro reports weak Q4 results | [23-May-2017]
  Sun Pharmaceuticals Industries to hold EGM | [20-May-2017]
  Sun Pharmaceutical Industries Limited - Corrigendum | [16-May-2017]
  Sun Pharmaceutical Industries Limited - Press Release | [16-May-2017]
  Sun Pharmaceuticals Industries to hold EGM | [13-May-2017]
  Sun Pharmaceutical Industries Limited - Shareholders meeting | [12-May-2017]
  Sun Pharmaceutical Industries Limited - Updates | [12-May-2017]
  Other announcement of Sun Pharmaceutical Industrie | [11-May-2017]
  Sun Pharmaceutical Industries Limited - Press Release | [02-May-2017]
  FDEC commences roll-out of Malaria demonstration project | [25-Apr-2017]
  Sun Pharmaceutical Industries Limited - Press Release | [25-Apr-2017]
  Sun Pharma drops 8.14% in six sessions | [24-Apr-2017]
  Sun Pharmaceutical Industries Limited - News Clarification | [24-Apr-2017]
  Sun Pharma slips on buzz Dadra unit gets 11 observations from USFDA | [21-Apr-2017]
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)